Sidoti Cuts Medifast (MED) to Neutral
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $11.95 +2.84%
Rating Summary:
4 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
4 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Shares of Medifast (NYSE: MED) have ticked lower over the last half hour or so of trade as Sidoti's Michael Halen lowered his investment rating on the stock from Buy to Neutral. The firm's price target was maintained at $21.
The stock is up more than 4 percent Wednesday afternoon as the stock gapped above the 200-day SMA. Volume is normal.
For an analyst ratings summary and ratings history on Medifast click here. For more ratings news on Medifast click here.
The stock is up more than 4 percent Wednesday afternoon as the stock gapped above the 200-day SMA. Volume is normal.
For an analyst ratings summary and ratings history on Medifast click here. For more ratings news on Medifast click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Limbach Holdings (LMB) to Underweight
- Canaccord Downgrades Northern Star Resources (NST:AU) (NESRF) to Hold
- JPMorgan Downgrades Bowman Consulting Group Ltd. (BWMN) to Underweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
Sidoti & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
